News & Updates
Joint Statement regarding the potential risks of carnitine treatment
In anticipation of concerns and possible confusion from media coverage of a recent article about possible atherogenic effects of trimethylamine oxide which could arise from carnitine administration, we post this statement in conjunction with other agencies. Read the statement at this link.
Our latest MMS Project
The Mitochondrial Medicine Society has completed studying the state of clinical mitochondrial medicine in North America. The study surveyed 32 clinicians that direct mitochondrial disease clinics to assess how clinical care is provided. The data has been compiled and we will present it to all of you soon.
Congratulations to our newly elected officers:
President: Dr. Sumit Parikh, Cleveland Clinic
Secretary/Treasurer: Dr. Amy Goldstein, Childrens Hospital of Pittsburgh
Program Chair: Dr. Greg Enns, Stanford
Councillors: Fernando Scaglia, Mary Kay Koenig and Phil Morgan.
The new officers will be instated at the UMDF meeting next month. The former president will continue to serve in an advisory capacity.
The MMS held a Clinic Director’s workshop at this year’s United Mitochondrial Disease Foundation Meeting in Bethesda Maryland in June of 2012. The goal of this workshop was to allow for any of us involved in evaluating and treating patients with mitochondrial disease to meet and share current individual approaches to diagnosis, evaluation, practice and care.
Fellowship in Mitochondrial Medicine
The North American Mitochondrial Disease Consortium (NAMDC) fellowship is soliciting applications. Read more here
The MMS List-Serv is now live and available to members.